12 articles for P Sleph
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of Highly Potent Liver X Receptorß Agonists.

Bristol-Myers Squibb
Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors.

Bristol-Myers Squibb Pharmaceutical Research Institute
Tetrahydroisoquinoline 1-carboxamides as growth hormone secretagogues.

Bristol-Myers Squibb Pharmaceutical Research Institute
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.

The Bristol-Myers Squibb Pharmaceutical Research Institute
(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.

Bristol Myers Squibb
Tetrazole based amides as growth hormone secretagogues.

Bristol-Myers Squibb Research and Development
Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.

Bristol-Myers Squibb Pharmaceutical Research Institute
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.

Bristol Myers Squibb
Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I.

Bristol-Myers Squibb Pharmaceutical Research Institute
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.

Bristol-Myers Squibb Pharmaceutical Research Institute
Potent Triazolopyridine Myeloperoxidase Inhibitors.

Bristol-Myers Squibb Research and Development
6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection

Hoffmann-La Roche